The future for vaccine development against Entamoeba histolytica.

Quach, Jeanie; St-Pierre, Joëlle; Chadee, Kris

Quach, Jeanie; St-Pierre, Joëlle; Chadee, Kris.

Afiliación

Quach J; Faculty of Medicine; Department of Microbiology, Immunology, and Infectious Diseases; Snyder Institute for Chronic Diseases; Gastrointestinal Research Group; University of Calgary; Calgary, AB Canada.
St-Pierre J; Faculty of Medicine; Department of Microbiology, Immunology, and Infectious Diseases; Snyder Institute for Chronic Diseases; Gastrointestinal Research Group; University of Calgary; Calgary, AB Canada.
Chadee K; Faculty of Medicine; Department of Microbiology, Immunology, and Infectious Diseases; Snyder Institute for Chronic Diseases; Gastrointestinal Research Group; University of Calgary; Calgary, AB Canada.

Hum Vaccin Immunother ; 10(6): 1514-21, 2014.

Article en En | MEDLINE | ID: mdl-24504133

Asunto(s)

Entamoeba histolytica/inmunología; Entamebiasis/prevención & control; Vacunas Antiprotozoos/aislamiento & purificación; Animales; Modelos Animales de Enfermedad; Descubrimiento de Drogas/tendencias; Humanos; Vacunas Antiprotozoos/inmunología

Palabras clave

DNA vaccine; Entamoeba histolytica; amebiasis; amebic colitis; amebic liver abscess; cell-mediated immunity; dysentery; immune response; immunopathogenesis; mucosal immune response

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Antiprotozoos / Entamoeba histolytica / Entamebiasis Límite: Animals / Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google